CrushSCI.com
245.4Average days
186Median days
77Fastest days
791Longest days
342025 publications

Paper Review Records

All Paper Review Records

14 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

372 days

Association between CYP2D6 genotype and treatment effectiveness and safety in 99 hospitalized patients with major depressive disorder a retrospective cohort study CYP2D6 genotype and antidepressant response

Authors
Aleksandra Petković Ćurčin; Aleksandra Jeremić; Danilo Joković; Gordana Šupić; Katarina Simić; Filip Milosavljević; Zvezdana Stojanović; Marin M. JukićShow moreShow less
Affiliations
1. Faculty of Medicine, Military Medical Academy, University of Defense, Belgrade, Serbia; 2. Institute for Medical Research, Military Medical Academy, Belgrade, Serbia; 3. Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; 4. Clinic for Psychiatry, Military Medical Academy, Belgrade, Serbia; 5. Department of Psychiatry, Berkshire Medical Center, Pittsfield, United States of America; 6. Department of Psychiatry and Psychotherapy, School of Medicine, Technische Universität München, München, Germany; 7. Department of Physiology and Pharmacology, Karolinska Institute, Solna, SwedenShow moreShow less
Source PDF DOI Publisher page
497 days

Large-scale analysis demonstrates the influence of CYP2C19 genotype on specific SSRI side effects

Authors
Chris Eijsbouts; Yunxuan Jiang; James R. Ashenhurst; Julie M. Granka; Steven Pitts; Adam Auton; Noura S. Abul-Husn; Alison Chubb; R. Ryanne WuShow moreShow less
Affiliations
1. 23andMe Research Institute, Palo Alto, USAShow moreShow less
Source PDF DOI Publisher page
77 days

Effects of CYP3A4, CYP3A5 , and ABCB1 genetic variants on tacrolimus metabolism during the early period after kidney transplantation

Authors
Nahathai Dukaew; Kajohnsak Noppakun; Mingkwan Na Takuathung; Nattharinee Kongta; Ratchanon Inpan; Naruemon Suyayai; Nut KoonrungsesomboonShow moreShow less
Affiliations
1. Department of Pharmacology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2. Clinical Research Center for Food and Herbal Product Trials and Development (CR-FAH), Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 3. School of Health Science, Mae Fah Luang University, Chiang Rai, Thailand; 4. Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 5. Pharmacoepidemiology and Statistics Research Center, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand; 6. Office of Research Administration, Chiang Mai University, Chiang Mai, Thailand; 7. Transplant and Dialysis Unit, Medical Nursing Division, Maharaj Nakorn Chiang Mai Hospital, Chiang Mai, Thailand; 8. Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM), Faculty of Medicine, Chiang Mai University, Chiang Mai, ThailandShow moreShow less
Source PDF DOI Publisher page
123 days

Understanding public perspectives on direct-to-consumer pharmacogenomic testing in the UK: a qualitative study

Authors
Amy Mathieson; Lisa Brunton; Stephanie Gillibrand; Ramona Moldovan; John H. McDermottShow moreShow less
Affiliations
1. Centre for Primary Care and Health Services Research, University of Manchester, Greater Manchester, UK; 2. Division of Evolution & Genomic Sciences, University of Manchester, Greater Manchester, UK; 3. Manchester Centre for Genomic Medicine, Saint Mary’s Hospital, Manchester, Greater Manchester, UK; 4. Department of Psychology, Babeș-Bolyai University, Cluj-Napoca, RomaniaShow moreShow less
Source PDF DOI Publisher page
119 days

Toxicity related to immunotherapy in urothelial cancer: Tumour genetic risk variants

Authors
JM Rodríguez-Piñas; A. Romero-Lorca; A. Novillo; M. Gaibar; M. Rubio; B. Antón-Pascual; S. Hernando; I. Alemany; FI Camacho; M. Cavanagh; M. Boiza; D. Marrupe; AM Martín; R. Khedaoui; A. Fernández-SantanderShow moreShow less
Affiliations
1. Department of Medicine, Faculty of Medicine, Health and Sports. Universidad Europea de Madrid, Madrid, Spain; 2. Human Genetic Variability Group, Hospital La Paz Institute for Health Research–IdiPAZ (La Paz University Hospital–Universidad Autónoma de Madrid–Getafe University Hospital–Universidad Europea de Madrid), Madrid, Spain; 3. Department of Cell Biology, Faculty of Medicine, Complutense University, Madrid, Spain; 4. Facultad HM de Ciencias de la Salud, Universidad Camilo José Cela, Instituto de Investigación Sanitaria HMHospitales, Madrid, Spain; 5. Department of Medical Oncology, Hospital Universitario Ramon y Cajal, Madrid, Spain; 6. Department of Medical Oncology, Hospital Universitario Fundación Alcorcón, Madrid, Spain; 7. Department of Pathological Anatomy, Hospital Universitario Fundación Alcorcón, Madrid, Spain; 8. Department of Pathological Anatomy, Hospital Universitario de Getafe, Madrid, Spain; 9. Department of Medical Oncology, Hospital Universitario de Getafe, Madrid, Spain; 10. Department of Pathological Anatomy, Hospital Universitario de Móstoles, Madrid, Spain; 11. Department of Medical Oncology, Hospital Universitario de Móstoles, Madrid, Spain; 12. Department of Medical Oncology, Hospital Universitario de Fuenlabrada, Madrid, Spain; 13. Department of Pathological Anatomy, Hospital Universitario de Fuenlabrada, Madrid, SpainShow moreShow less
Source PDF DOI Publisher page
296 days

Beyond the ‘Pregnancy Black Box’: a global roadmap for artificial intelligence-driven pharmacogenomics in maternal-neonatal health

Authors
Mohamed A. IsmailShow moreShow less
Affiliations
1. Hamad Medical Corporation, Doha, QatarShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.